Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15705529rdf:typepubmed:Citationlld:pubmed
pubmed-article:15705529lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C0007277lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:15705529lifeskim:mentionsumls-concept:C0445254lld:lifeskim
pubmed-article:15705529pubmed:issue2-3lld:pubmed
pubmed-article:15705529pubmed:dateCreated2005-2-11lld:pubmed
pubmed-article:15705529pubmed:abstractTextPrevious studies have shown that glomus cells of the carotid body express 5-hydroxytryptamine (5-HT). The aim of this study was to elucidate the role of 5-HT on the hypoxic sensory response (HSR) of the carotid body. Sensory activity was recorded from multi-fiber (n=16) and single-fiber (n=8) preparations of ex vivo carotid bodies harvested from anesthetized, adult rats. 5-HT (3 microM) had no significant effect on the magnitude or on the onset of the HSR. However, 5-HT consistently prolonged the time necessary for the sensory activity to return to baseline following the termination of the hypoxic challenge. Ketanserin (40 microM), a 5-HT2 receptor antagonist completely prevented 5-HT-induced prolongation of the HSR, whereas had no effect on the control HSR (onset, magnitude, and time for decay without 5-HT). Carotid bodies expressed 5-HT, but hypoxia did not facilitate 5-HT release. These observations suggest that 5-HT is not critical for the HSR of the rat carotid body, but it modulates the dynamics of the HSR via its action on 5-HT2 receptors.lld:pubmed
pubmed-article:15705529pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15705529pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15705529pubmed:languageenglld:pubmed
pubmed-article:15705529pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15705529pubmed:citationSubsetIMlld:pubmed
pubmed-article:15705529pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15705529pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15705529pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15705529pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15705529pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15705529pubmed:statusMEDLINElld:pubmed
pubmed-article:15705529pubmed:monthFeblld:pubmed
pubmed-article:15705529pubmed:issn1569-9048lld:pubmed
pubmed-article:15705529pubmed:authorpubmed-author:KumarG KGKlld:pubmed
pubmed-article:15705529pubmed:authorpubmed-author:PrabhakarN...lld:pubmed
pubmed-article:15705529pubmed:authorpubmed-author:JaconoF JFJlld:pubmed
pubmed-article:15705529pubmed:authorpubmed-author:PengY-JYJlld:pubmed
pubmed-article:15705529pubmed:issnTypePrintlld:pubmed
pubmed-article:15705529pubmed:day15lld:pubmed
pubmed-article:15705529pubmed:volume145lld:pubmed
pubmed-article:15705529pubmed:ownerNLMlld:pubmed
pubmed-article:15705529pubmed:authorsCompleteYlld:pubmed
pubmed-article:15705529pubmed:pagination135-42lld:pubmed
pubmed-article:15705529pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:meshHeadingpubmed-meshheading:15705529...lld:pubmed
pubmed-article:15705529pubmed:year2005lld:pubmed
pubmed-article:15705529pubmed:articleTitleModulation of the hypoxic sensory response of the carotid body by 5-hydroxytryptamine: role of the 5-HT2 receptor.lld:pubmed
pubmed-article:15705529pubmed:affiliationDepartment of Medicine, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA.lld:pubmed
pubmed-article:15705529pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15705529pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15705529pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:15705529pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15705529lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15705529lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15705529lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15705529lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15705529lld:pubmed